Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Depression Interventions After Acute Coronary Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Hospitalized for ACS defined as unstable angina or MI~* BDI greater or equal to 10 and \< 15 2-6 months post-ACS on each of 2 occasions, or BDI greater than 15 on one occasion~* Age at least 35 years~* Fluent in English or Spanish~* Able to complete baseline assessment within 2-6 months of index ACS event~* Able and willing to provide informed consent~Exclusion Criteria:~* Presence of non-cardiac condition likely to terminate fatally within 1 year~* Inaccessibility for intervention or follow-up (e.g., plans to move from the area)~* Cognitive impairment~* Need for immediate psychiatric intervention (i.e., requiring hospitalization or psychiatric intervention within 72 hours)~* Suicidal ideation~* Major psychiatric co-morbidity (current or by history) including active psychosis, bipolar disorder, or overt personality disorder~* Active substance abuse or dependency~* Chronic renal failure (receiving chronic dialysis treatment, or estimated glomerular filtration rate...\[eGFR\] \< 30 ml/min/1.73 m2) or moderate/severe liver disease (e.g., esophageal varices, portal hypertension, encephalopathy, GI bleeding)~* Participation in another clinical trial for the treatment of depression.

- Gender: ALL
- Minimum Age: 35 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Referred Care (Type: ACTIVE_COMPARATOR): Immediately after the initial post-ACS screening, the participant's physician will be notified in writing if the participant is depressed according to the BDI. Depending upon the physician's own evaluation of the participant, he or she may elect to defer depression treatment, initiate it, or to refer the patient to a mental health specialist.
- Stepped Care (Type: EXPERIMENTAL): Stepped Care participants will be given a description of the choices available in this arm, including choosing antidepressant medication and/or telephone-based, Problem-Solving Therapy (PST). If the patient is randomized to Stepped Care, their physician will be informed that depression treatment is being provided by the trial. Patients will select their preferred treatment approach. Depression symptoms will be monitored to determine whether the patient is improving relative to his/her baseline score. Relapse monitoring and maintenance therapy will continue for the duration of the study.

Based on this trial design, predict the completion outcome and termination type (if applicable).